Search results
How many seats did Reform UK win - and why they don't match its vote share?
Yahoo News UK· 2 days agoWhat is proportional representation? Those who argue that FPTP is unfair propose a different voting...
The Zacks Analyst Blog Highlights California Water Service, Atmos Energy, Portland General Electric,...
Zacks via Yahoo Finance UK· 3 hours agoPortland General Electric Company has a beta of 0.58 and a current dividend yield of 4.71%....
Acomo And Two More Top Dividend Stocks On Euronext Amsterdam
Simply Wall St. via Yahoo Finance UK· 7 hours agoAs global markets navigate through varying economic signals, the Netherlands' stock market remains a...
Huawei-backed Chinese electric vehicle Avatr all geared for UAE launch
Gulf News· 6 days agoAvatr Technology enters distribution deal with UAE's Smart Mobility International
Labour election victories raise stakes for 'levelling up' project
Chronicle Live via Yahoo News UK· 3 hours ago“It will pursue further the new mayoral model. But it’s hard to discern its thinking more broadly...
Loomis And Two Other Leading Dividend Stocks In Sweden
Simply Wall St. via Yahoo Finance UK· 10 hours agoAs global markets navigate through varying economic signals, Sweden's market remains a focal point...
Ian McConnell: Scottish stalwart in takeover sights as distiller prospers
The Herald· 8 hours agoThe fate of Wood remains uncertain after the deadline for a Middle Eastern suitor to make a firm bid was extended last week. Wood announced on Wednesday that Dubai-based Sidara had been given ...
How Will a Labour Government Impact my Finances?
Morningstar· 3 hours ago"Although Labour's manifesto was relatively light on detail, its 'Plan for Growth' document published in January provides an insight into what the key...
Arsenal have found the perfect fit, while new Saka partner could be game changer
Talk Sport· 15 hours agoIf the transfer market was run like a dating app, Mikel Arteta’s search criteria would see him tick...
DEFENCE RECEIVES NO OBJECTION LETTER FROM HEALTH CANADA FOR PHASE I TRIAL OF ITS ACCUM-002 (ACCUTOX)
PharmiWeb· 5 hours agoEQS-News: Defence Therapeutics Inc. / Key word(s): MiscellaneousDEFENCE RECEIVES NO OBJECTION LETTER FROM HEALTH CANADA FOR PHASE I TRIAL OF ITS ACCUM-002 (ACCUTOX) AS AN ANTI-CANCER MOLECULE ...